ASweetLife Team, Author at ASweetLife

Abbott Receives FDA Clearance for New FreeStyle Test Strips

Following the recent clearance of its FreeStyle Lite® blood glucose test strips, Abbott announced that it has also received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new FreeStyle blood glucose test strips. The new FreeStyle test strips minimize interference during blood glucose testing and are designed to offer a better testing experience...

Bristol-Myers Squibbs’ Dapagliflozin Demonstrated Improved Glycemic Control in Adults with Type 2 Diabetes

Bristol-Myers announced that findings from a 24-week Phase 3 clinical study, published online in the latest issue of Diabetes Care, demonstrated that the investigational drug dapagliflozin, administered as a monotherapy, achieved statistically significant mean reductions at 5 mg and 10 mg doses once daily in the primary endpoint of HbA1c levels...

101 Places Not To See Before You Die

Now out from HarperPaperbacks, 101 Places Not To See Before You Die -- by ASweetLife contributor Catherine Price -- is a guide to some of the least appealing destinations and experiences in the world.

Eli Lilly and Walmart to Provide Affordable Insulin

Eli Lilly and Company announced they're teaming up with Walmart to provide an affordable insulin option for people with diabetes. Beginning in mid-September, Lilly's Humulin(R) brand of insulin will be available in Walmart pharmacies...

Novo Nordisk Re-Initiates Phase 3 Development of Liraglutide (Victoza) for Obesity Treatment

Novo Nordisk today announced the decision to re-initiate the global phase 3 development program of liraglutide for the treatment of obesity. Following the US approval of Victoza for the treatment of type 2 diabetes, Novo Nordisk has been in dialogue with the FDA regarding the further progression of the development program investigating...

Depomed Recalls Type 2 Diabetes Drug Glumetza

Drug developer Depomed Inc announced it would recall 52 lots of its type 2 diabetes drug Glumetza due to the presence of traces of a certain chemical in the tablet's 500 mg bottle, according to a Reuters report...

Neurocrine Biosciences and Boehringer Ingelheim to Jointly Research and Develop Type 2 Diabetes Drug

Neurocrine Biosciences, Inc. announcedthat they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of type 2 diabetes. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is...

New Type 2 Diabetes Drug Bydureon Shows Better Results Than Januvia

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. announced results from DURATION-4, the fourth in a series of studies designed to test the superiority of Bydureon (exenatide extended-release for injectable suspension), an investigational type 2 diabetes therapy, as compared to other type 2 diabetes medications...

Hemoglobin A1c Levels Differ in Black and White Persons

A new study published in the Annals of Internal Medicine shows hemoglobin A1c levels differ in black and white persons independent of glucose levels. The study looked at 1581 non-Hispanic black and white persons in the Atlanta area between 18 and 87 years of age who did not have known diabetes...

White Rice Ups Risk of Type 2 Diabetes

A new study has found that consuming white rice appears to be associated with a higher risk for developing type 2 diabetes in comparison with those who consume more brown rice, according to a EurekAlert report. A team of Harvard researchers...